Pelvic infection F7: Pelvic infection with pain, pleural adhension, chronic enteritis, hepatitis, hematoporphyria or PMS.

1. Chronic pelvic infections: Of 64 patients taking F7 formula or its modifications for a month showed 21 cured (32.81 percent), 37 improved (57.81 percent) while other six did not (9.37 percent).

2. Pleural adhension: 60 patients: 15 with adhension more than 8 cm; 17 have adhension between 5 to 8 cm while the other 28 were below 5 cm adhension. All took F7 or its modification and 33 cured (55 percent), 23 significantly improved (38.33 percent), two improved and two did not improve.

3. Chronic enteritis: 156 patients took F7 or its modification for up to two months and 94 cured (60.25 percent), 9 significantly improved (5.76 percent), 42 improved (26.92 percent) and 11 did not improve (7.05 percent).

4. Chronic hepatitis: 25 patients took F7 with regular medication found: 24/25 appetite improved; 25/25 liver pain disappeared; 24/25 jaundice gone and all liver function test improved.

5. PMS: 486 patients took F7 and 452 were cured or improved (93.02 percent).

6. Hematoporphyria: Eight patients with severe stomach ache and bloody urine took F7 and all were cured.

7. Orchitis or testis: 24 patients age from 27 to 41 years old took F7 or its modification for five weeks and 17 cured (70.83 percent), six significantly improved (25 percent) and one did not.

Side effects and toxicity: There is no known side effect or toxicity on F7 formula.